Holder evidence
31
SEC ownership of Catheter Precision, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001716621.
Lead holder
Jenkins Casey A.
13D/G signal
Jenkins Casey A.
Latest evidence
31 Mar 2026
- CIK
- 0001716621
- Symbol
- VTAK on NYSE
- Location
- Fort Mill, SC
- SEC evidence mix
- 13D/G, 3/4/5, and 13F
- Lead holder
- Jenkins Casey A.
- Latest large-stake holder
- Jenkins Casey A.
- Latest evidence date
- 31 Mar 2026
Issuer identity
Ownership snapshot
Ownership snapshot
Top shareholders of Catheter Precision, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Jenkins Casey A.
13D/G signal
Jenkins Casey A.
Evidence rows
31
Latest as of
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 9.9%
13D/G row: Jenkins Casey A.
Showing 1-8 of 31 holder rows.
Rank 1 holder
Jenkins Casey A.
13D/G
- Ownership
- 9.9%
- Position
- $233K
Rank 2 holder
Gregory Castaldo
13D/G
- Ownership
- 7.5%
- Position
- $355.1K
Rank 3 holder
Joseph Reda
13D/G
- Ownership
- 7.5%
- Position
- $355.1K
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jenkins Casey A. |
13D/G
|
9.9%
|
$233,028
832,243 shares
|
$0 | 31 Dec 2024 |
| Gregory Castaldo |
13D/G
|
7.5%
|
$355,115
176,674 shares
|
$0 | 06 Feb 2026 |
| Joseph Reda |
13D/G
|
7.5%
|
$355,115
176,674 shares
|
$0 | 06 Feb 2026 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$257,746
1,120,635 shares
|
+$27,551 | 30 Jun 2025 |
| David A. Jenkins |
3/4/5
13D/G
Chairman of the Board and CEO, Director · JENKINS DAVID A
|
2.1%
from 13D/G
|
$562,665
403,397 shares
mixed-class rows
|
— | 26 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.2%
|
$48,135
47,659 shares
|
— | 31 Mar 2026 |
| Virtu Financial LLC |
13F
Company
|
0.63%
|
$14,000
13,472 shares
|
— | 31 Mar 2026 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
0.61%
|
$13,268
13,137 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 31 May 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-17 of 17 reporting-owner rows connected to Catheter Precision, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
17
Lead holder
David A. Jenkins
Net 12M change
$0
Latest report
26 Mar 2026
Recent insider transactions for Catheter Precision, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| David A. Jenkins | VTAK | Options (Right to Buy) | Award | 40,000 | 40,000 | 26 Mar 2026 | Direct | |||
| Philip J. Anderson | VTAK | Options (Right to Buy) | Award | 40,000 | 40,000 | 26 Mar 2026 | Direct | |||
| Andrew Arno | VTAK | Options (Right to Buy) | Award | 40,000 | 40,000 | 26 Mar 2026 | Direct | |||
| James J. Caruso | VTAK | Options (Right to Buy) | Award | 40,000 | 40,000 | 26 Mar 2026 | Direct | |||
| Martin J. Colombatto | VTAK | Options (Right to Buy) | Award | 40,000 | 40,000 | 26 Mar 2026 | Direct | |||
| David A. Jenkins | VTAK | Series J Preferred Stock | Other | 6,998 | 6,998 | 12 Feb 2026 | See Footnote | |||
| David A. Jenkins | VTAK | Series J Preferred Stock | Other | 2,491 | 2,491 | 12 Feb 2026 | Direct | |||
| David A. Jenkins | VTAK | Series M Common Stock Purchase Warrant | Other | 170,000 | 170,000 | 31 Dec 2025 | See Footnote 3 | |||
| David A. Jenkins | VTAK | Series M Common Stock Purchase Warrant | Other | 170,000 | 170,000 | 31 Dec 2025 | Direct | |||
| James J. Caruso | VTAK | Common Stock | Conversion of derivative security | 455.6% | 41 | 50 | 05 Dec 2025 | Direct | ||
| James J. Caruso | VTAK | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -7.93 | 0 | 05 Dec 2025 | Direct | ||
| David A. Jenkins | VTAK | Common Stock | Conversion of derivative security | 850.8% | 30,942 | 34,579 | 05 Dec 2025 | See Footnote | ||
| David A. Jenkins | VTAK | Common Stock | Conversion of derivative security | 695.3% | 12,064 | 13,799 | 05 Dec 2025 | Direct | ||
| David A. Jenkins | VTAK | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -5,879 | 0 | 05 Dec 2025 | See Footnote | ||
| David A. Jenkins | VTAK | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -2,292 | 0 | 05 Dec 2025 | Direct | ||
| Andrew Arno | VTAK | Options (Right to Buy) | Award | 50,000 | 50,000 | 12 Aug 2025 | Direct | |||
| James Joseph Caruso | VTAK | Options (Right to Buy) | Award | 50,000 | 50,000 | 12 Aug 2025 | Direct | |||
| Martin J. Colombatto | VTAK | Options (Right to Buy) | Award | 50,000 | 50,000 | 12 Aug 2025 | Direct | |||
| David A. Jenkins | VTAK | Options (Right to Buy) | Award | 500,000 | 500,000 | 12 Aug 2025 | Direct |
* indicates a reported price that failed the local validity check.